Published in Prev Chronic Dis on February 15, 2010
Designing for diffusion: how can we increase uptake of cancer communication innovations? Patient Educ Couns (2010) 1.10
A Multistate Asian-Language Tobacco Quitline: Addressing a Disparity in Access to Care. Am J Public Health (2015) 0.80
The impact of a state-sponsored mass media campaign on use of telephone quitline and web-based cessation services. Prev Chronic Dis (2014) 0.77
Promoting tobacco cessation and smoke-free workplaces through community outreach partnerships in Puerto Rico. Prog Community Health Partnersh (2014) 0.76
How Tobacco Quitline Callers in 38 US States Reported Hearing About Quitline Services, 2010-2013. Prev Chronic Dis (2016) 0.75
Telephone counselling for smoking cessation. Cochrane Database Syst Rev (2006) 5.24
Tobacco cessation quitlines in North America: a descriptive study. Tob Control (2007) 4.03
Telephone counseling for smoking cessation: rationales and meta-analytic review of evidence. Health Educ Res (1996) 3.91
Increased reach and effectiveness of a statewide tobacco quitline after the addition of access to free nicotine replacement therapy. Tob Control (2006) 3.49
Quitlines in North America: evidence base and applications. Am J Med Sci (2003) 3.35
Reach, efficacy, and cost-effectiveness of free nicotine medication giveaway programs. J Public Health Manag Pract (2005) 2.51
Tobacco quitlines: looking back and looking ahead. Tob Control (2007) 2.05
State-specific prevalence of current cigarette smoking among adults and secondhand smoke rules and policies in homes and workplaces--United States, 2005. MMWR Morb Mortal Wkly Rep (2006) 1.74
State-specific prevalence of cigarette smoking among adults and quitting among persons aged 18-35 years--United States, 2006. MMWR Morb Mortal Wkly Rep (2007) 1.49
Telephone counseling as adjuvant treatment for nicotine replacement therapy in a "real-world" setting. Prev Med (2000) 1.45
Organization, financing, promotion, and cost of U.S. quitlines, 2004. Am J Prev Med (2006) 1.30
Quitlines a tool for research and dissemination of evidence-based cessation practices. Am J Prev Med (2007) 1.28
Increasing reach of quitline services in a US state with comprehensive tobacco treatment. Tob Control (2007) 1.24
Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol Rev (2004) 9.30
Time to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence. Nicotine Tob Res (2007) 5.54
Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol (2005) 5.12
A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. Arch Gen Psychiatry (2009) 4.66
A multiple motives approach to tobacco dependence: the Wisconsin Inventory of Smoking Dependence Motives (WISDM-68). J Consult Clin Psychol (2004) 4.24
Preventing 3 million premature deaths and helping 5 million smokers quit: a national action plan for tobacco cessation. Am J Public Health (2004) 3.71
Effectiveness of implementing the agency for healthcare research and quality smoking cessation clinical practice guideline: a randomized, controlled trial. J Natl Cancer Inst (2004) 3.26
A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction. PLoS Genet (2008) 3.25
Assessing tobacco dependence: a guide to measure evaluation and selection. Nicotine Tob Res (2006) 2.77
Prevalence and predictors of transitions in smoking behavior among college students. Health Psychol (2004) 2.64
Have we lost our way? The need for dynamic formulations of smoking relapse proneness. Addiction (2002) 2.48
New methods for tobacco dependence treatment research. Ann Behav Med (2011) 2.44
The multiphase optimization strategy for engineering effective tobacco use interventions. Ann Behav Med (2011) 2.43
Life before and after quitting smoking: an electronic diary study. J Abnorm Psychol (2006) 2.30
Predicting relapse back to smoking: contrasting affective and physical models of dependence. J Consult Clin Psychol (2002) 2.18
Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success. Am J Psychiatry (2012) 2.02
Treating tobacco use and dependence: an evidence-based clinical practice guideline for tobacco cessation. Chest (2002) 2.02
Smoking cessation via the internet: a randomized clinical trial of an internet intervention as adjuvant treatment in a smoking cessation intervention. Nicotine Tob Res (2006) 2.02
Clinical practice. Treating smokers in the health care setting. N Engl J Med (2011) 1.99
Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics. Arch Intern Med (2009) 1.95
Cytokine response patterns, exposure to viruses, and respiratory infections in the first year of life. Am J Respir Crit Care Med (2004) 1.87
Refining the tobacco dependence phenotype using the Wisconsin Inventory of Smoking Dependence Motives. J Abnorm Psychol (2008) 1.86
Human neuronal acetylcholine receptor A5-A3-B4 haplotypes are associated with multiple nicotine dependence phenotypes. Nicotine Tob Res (2009) 1.84
Bidirectional interactions between viral respiratory illnesses and cytokine responses in the first year of life. J Allergy Clin Immunol (2005) 1.81
Smoking withdrawal dynamics: I. Abstinence distress in lapsers and abstainers. J Abnorm Psychol (2003) 1.79
Framing the consequences of childhood obesity to increase public support for obesity prevention policy. Am J Public Health (2013) 1.75
Using mediational models to explore the nature of tobacco motivation and tobacco treatment effects. J Abnorm Psychol (2008) 1.72
A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling. Nicotine Tob Res (2008) 1.70
Smoking withdrawal dynamics: II. Improved tests of withdrawal-relapse relations. J Abnorm Psychol (2003) 1.64
Development of the Brief Wisconsin Inventory of Smoking Dependence Motives. Nicotine Tob Res (2010) 1.63
Assessing dimensions of nicotine dependence: an evaluation of the Nicotine Dependence Syndrome Scale (NDSS) and the Wisconsin Inventory of Smoking Dependence Motives (WISDM). Nicotine Tob Res (2008) 1.62
Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial. J Am Coll Cardiol (2010) 1.61
Psychiatric disorders in smokers seeking treatment for tobacco dependence: relations with tobacco dependence and cessation. J Consult Clin Psychol (2010) 1.60
Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment. Addiction (2010) 1.60
Taxes on sugar-sweetened beverages: results from a 2011 national public opinion survey. Am J Prev Med (2013) 1.60
Tobacco withdrawal components and their relations with cessation success. Psychopharmacology (Berl) (2011) 1.60
Smoking-cessation media campaigns and their effectiveness among socioeconomically advantaged and disadvantaged populations. Am J Public Health (2008) 1.57
Chest computed tomography scores of severity are associated with future lung disease progression in children with cystic fibrosis. Am J Respir Crit Care Med (2011) 1.56
Reproducibility of a scoring system for computed tomography scanning in cystic fibrosis. J Thorac Imaging (2006) 1.56
Effects of dog ownership and genotype on immune development and atopy in infancy. J Allergy Clin Immunol (2004) 1.55
A pilot study on mindfulness based stress reduction for smokers. BMC Complement Altern Med (2007) 1.55
Psychological mediators of bupropion sustained-release treatment for smoking cessation. Addiction (2008) 1.53
The role of health care systems in increased tobacco cessation. Annu Rev Public Health (2008) 1.53
Life 1 year after a quit attempt: real-time reports of quitters and continuing smokers. Ann Behav Med (2012) 1.52
Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. Am Heart J (2011) 1.50
A controlled, randomized, double-blind trial of prophylaxis against jaundice among breastfed newborns. Pediatrics (2005) 1.47
Smoker characteristics and smoking-cessation milestones. Am J Prev Med (2011) 1.47
The theory of "truth": how counterindustry campaigns affect smoking behavior among teens. Health Psychol (2005) 1.46
Association between mucoid Pseudomonas infection and bronchiectasis in children with cystic fibrosis. Radiology (2009) 1.42
Validating measures of scanned information exposure in the context of cancer prevention and screening behaviors. J Health Commun (2009) 1.42
Sex-related differences in immune development and the expression of atopy in early childhood. J Allergy Clin Immunol (2006) 1.39
Polygenic risk and the developmental progression to heavy, persistent smoking and nicotine dependence: evidence from a 4-decade longitudinal study. JAMA Psychiatry (2013) 1.38
Cancer information scanning and seeking in the general population. J Health Commun (2010) 1.36
Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough! J Pediatr (2005) 1.36
Longitudinal evaluation of bronchopulmonary disease in children with cystic fibrosis. Pediatr Pulmonol (2003) 1.35
Efficacy of bupropion alone and in combination with nicotine gum. Nicotine Tob Res (2007) 1.33
Why two smoking cessation agents work better than one: role of craving suppression. J Consult Clin Psychol (2011) 1.33
Smoking withdrawal dynamics: III. Correlates of withdrawal heterogeneity. Exp Clin Psychopharmacol (2003) 1.33
Progression of college-age cigarette samplers: what influences outcome. Addict Behav (2005) 1.32
Interventions for tobacco smoking. Annu Rev Clin Psychol (2013) 1.32
Organization, financing, promotion, and cost of U.S. quitlines, 2004. Am J Prev Med (2006) 1.30
Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis. Am J Respir Crit Care Med (2003) 1.29
Helping smokers quit--opportunities created by the Affordable Care Act. N Engl J Med (2014) 1.28
Integrating smoking cessation treatment into primary care: an effectiveness study. Prev Med (2004) 1.28
Associations between phenylthiocarbamide gene polymorphisms and cigarette smoking. Nicotine Tob Res (2005) 1.27
Alcohol consumption, smoking urge, and the reinforcing effects of cigarettes: an ecological study. Psychol Addict Behav (2008) 1.26
Effective tobacco dependence treatment. JAMA (2002) 1.25
Smoke, the chief killer--strategies for targeting combustible tobacco use. N Engl J Med (2014) 1.24
Nicotinic acetylcholine receptor variation and response to smoking cessation therapies. Pharmacogenet Genomics (2013) 1.24
The effects of state counterindustry media campaigns on beliefs, attitudes, and smoking status among teens and young adults. Prev Med (2003) 1.23